Contract analysis
Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.
Contract analysis / revenue-projection-analysis.xlsx
revenue-projection-analysis.xlsx
High · 0
Medium · 0
Standard · 1
[sheet: Summary]
Standard
⚑ Commercial term
[sheet: Summary] Item | Detail Client | Penterra Pharmaceuticals Corp. (PPC) CSA Counterparty | Penterra Biopharma International DAC (PBI) CSA Effective Date | July 1, 2012 PCT Payment | $312,000,000 Tax Years Analyzed | 2017, 2018, 2019, 2020 Products Covered | Veritaxol (oncology), Imvara (immunology), Cerulon (rare disease) Americas Territory | North America, Central America, South America, Caribbean (PPC) Non-Ame